Octavio Espinoza, Chief Financial Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 3,608 shares at $188.31 ($679K) on 2025-12-12, disclosed to the SEC on 2025-12-16.
Seasonal sale ($679k) by Chief Financial Officer — this insider has traded LGND in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $188.31 | 1,804 | $340K | 50.0% |
| 2 | $188.31 | 1,804 | $340K | 50.0% |
| Total | $188.31 avg | 3,608 | $679K | 100% |
| Filing → |
| LGND | SELL | 2026-03-06 | $5.5M | — | Filing → |
| LGND | BUY | 2025-05-13 | $156K | — | Filing → |
| LGND | SELL | 2025-03-06 | $575K | — | Filing → |